FSD Pharma Inc. filed a Form 6-K with the SEC on March 5, 2024, confirming it will submit annual reports under Form 20-F. The event is considered significant from an equity investor perspective, with a neutral sentiment.
AI Assistant
QUANTUM BIOPHARMA LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.